The Food and Drug Administration approved EnteroMedics Inc.'s (Nasdaq: ETRM) VBLOC vagal blocking therapy for obesity. Shares of the medical device company gained 21 cents to $1.39.
FDA approves EnteroMedics device
January 14, 2015 at 12:39 PM EST
